Literature DB >> 7636159

Schistosoma haematobium in the baboon (Papio anubis): assessment of protection levels against either a single mass challenge or repeated trickle challenges after vaccination with irradiated schistosomula.

G D Reid1, R F Sturrock, R A Harrison, R P Tarara.   

Abstract

Baboons vaccinated intramuscularly with three times 9000 20 krad irradiated Schistosoma haematobium schistosomula at monthly intervals were exposed percutaneously to either a single mass challenge of 3000 (VMC) or ten, weekly trickle challenges of 300 (VTC) normals S. haematobium cercariae. Unvaccinated mass (MCC) or trickle (TCC) challenge controls were exposed simultaneously. Faecal and urine egg production was delayed in the vaccinated groups which also had reduced adult, particularly female, worm recoveries. Total faecal, urine and tissue eggs were lower in the vaccinated groups, as also were the size of granulomata and the gross pathology and severity of inflammatory responses in the bladder and ureters, except for an increased proportion of tissue eggs in the livers of vaccinated animals. Differences in pathology between groups were less marked in the other organs. Most indices were reduced in the trickle versus the mass challenge control groups. Some of these trends were statistically significant, mostly in the trickle vaccination group (VTC), but others were not. Compared with the appropriate unvaccinated controls, the percentage reduction for the trickle challenge (VTC) group (73%) was three times greater than that of the mass challenge (VMC) group (23%). Overall, the protective effect of vaccination was more clearly demonstrated in the trickle than in the mass challenge groups. This conclusion is based on a single experiment. Nevertheless, because trickle infections probably approximate more closely to what humans receive naturally, it is recommended that they should be used for future testing of all potential vaccines in baboons.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7636159     DOI: 10.1017/s0022149x00014024

Source DB:  PubMed          Journal:  J Helminthol        ISSN: 0022-149X            Impact factor:   2.170


  6 in total

1.  Influence of pattern of exposure, parasite genetic diversity and sex on the degree of protection against reinfection with Schistosoma mansoni.

Authors:  M Dumont; H Moné; G Mouahid; M A Idris; M Shaban; J Boissier
Journal:  Parasitol Res       Date:  2007-02-20       Impact factor: 2.289

2.  Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons.

Authors:  Souvik Karmakar; Weidong Zhang; Gul Ahmad; Workineh Torben; Mayeen U Alam; Loc Le; Raymond T Damian; Roman F Wolf; Gary L White; David W Carey; Darrick Carter; Steven G Reed; Afzal A Siddiqui
Journal:  Vaccine       Date:  2014-01-04       Impact factor: 3.641

3.  Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine.

Authors:  Weidong Zhang; Gul Ahmad; Workineh Torben; Zahid Noor; Loc Le; Raymond T Damian; Roman F Wolf; Gary L White; Maria Chavez-Suarez; Ronald B Podesta; Ronald C Kennedy; Afzal A Siddiqui
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

4.  Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model.

Authors:  Gul Ahmad; Weidong Zhang; Workineh Torben; Raymond T Damian; Roman F Wolf; Gary L White; Maria Chavez-Suarez; Ronald C Kennedy; Afzal A Siddiqui
Journal:  Vaccine       Date:  2009-03-10       Impact factor: 3.641

5.  Role of adult worm antigen-specific immunoglobulin E in acquired immunity to Schistosoma mansoni infection in baboons.

Authors:  M Nyindo; T M Kariuki; P W Mola; I O Farah; L Elson; R E Blanton; C L King
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

Review 6.  Experimental vaccines in animal models for schistosomiasis.

Authors:  Afzal A Siddiqui; Gul Ahmad; Raymond T Damian; Ronald C Kennedy
Journal:  Parasitol Res       Date:  2008-02-08       Impact factor: 2.289

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.